20 September, 2022
Fortress Diagnostics Ltd have received Invest NI Grants for Research and Development, supporting company innovation in services, products and processes. Part financed by the Investment for Growth and Jobs Programme for Northern Ireland, co-financed by the European Regional Development Fund 2014-2020. One project was the development of the Vitamin D ELISA Assay which has been implemented over the past number of years and we are pleased to announce the assay has been successfully developed and released to the market. The second and on-going project is the development of a Multiplex Mycotoxin Rapid Device. We hope that this project will lead to the development of a rapid and easy-to-use device for the detection of mycotoxins.
Fortress Diagnostics Research and Development (R&D) team is committed to discovering and developing novel and innovative clinical testing solutions to provide the highest level of healthcare globally, through continued investment in new technologies. We are proud to have received the Invest NI funding for Research and Development and of the results our team have achieved during these projects.
More information on the Vitamin D ELISA Assay can be found here; https://www.fortressdiagnostics.com/products/immunoassays/immunoassays-elisa.
